Ana Pueyo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ana Pueyo has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Elisa Vilades
Department of Ophthalmology, Miguel Servet University Hospital, 50009 Zaragoza, Spain
2 shared publications - Almudena López-Dorado
Biomedical Engineering Group, Department of Electronics, University of Alcalá, 28801 Alcalá de Henares, Spain
1 shared publication Anna Maino
Manchester Royal Eye Hospital, Manchester, UK
1 shared publicationAurore Muselier
Centre Ophtalmologique Saint Paul, Paris, France
1 shared publication- Barbara Cvenkel
Department of Ophthalmology, Faculty of Medicine, University Medical Centre Ljubljana, University of Ljubljana, Ljubljana, Slovenia
1 shared publication Beatriz Cordon
Ophthalmology Department, Miguel Servet University Hospital, Zaragoza, Spain
1 shared publication
Latest Publications
- Open Access
- 7 August 2025
- Published by Wiley in Acta Ophthalmologica
- Vol. 104 (2) , e204-e215
Competency‐based European training requirements for the specialty of ophthalmology. Recommendations from the UEMS section of ophthalmology and the European Board of Ophthalmology
Purpose: Ophthalmology encompasses comprehensive medical and surgical care for patients with diverse visual system disorders, significantly impacting eye health, vision, and quality of life. European ophthalmologists undergo specialized residency training to acquire necessary competencies, emphasizing theoretical knowledge, clinical and surgical skills, and professional behaviour. The European Union of Medical Specialists (UEMS) and the European Board of Ophthalmology (EBO) advocate for competency‐based medical education (CBME), standardized training frameworks, and harmonized assessments across Europe. Methods: In 2023, a survey among European ophthalmologists demonstrated broad consensus on establishing unified training requirements. Subsequently, a Core Working Group developed European Training Requirements (ETRs) for ophthalmology, detailing curricula, subspecialty rotations, and Entrustable Professional Activities (EPAs) across a structured four‐year residency. Results: These ETRs, formally approved by UEMS in October 2024, incorporate simulation‐based training, workplace‐based assessments (WPBA), and innovative evaluation methods such as electronic portfolios. Certification as a European Specialist in Ophthalmology involves passing rigorous summative assessments, including the European Board of Ophthalmology Diploma (EBOD) examination. Training institutions must offer substantial clinical exposure, robust infrastructure, and comprehensive educational resources. Faculty support, continuous quality assurance, regular audits, and clinical governance frameworks are essential. Conclusion: The ETRs also highlight the importance of interprofessional collaboration and encourage subspecialty expansion in emerging areas like ophthalmic oncology and global ophthalmology. Designed as a dynamic, “living document,” the ETRs will evolve with scientific and technological advancements, supporting high‐quality ophthalmic education and practice while respecting national diversity and sovereignty.
- 7 August 2025
- Published by Wiley in Acta Ophthalmologica
- Vol. 104 (2) , e204-e215
Open AccessCompetency‐based European training requirements for the specialty of ophthalmology. Recommendations from the UEMS section of ophthalmology and the European Board of Ophthalmology
Purpose: Ophthalmology encompasses comprehensive medical and surgical care for patients with diverse visual system disorders, significantly impacting eye health, vision, and quality of life. European ophthalmologists undergo specialized residency training to acquire necessary competencies, emphasizing theoretical knowledge, clinical and surgical skills, and professional behaviour. The European Union of Medical Specialists (UEMS) and the European Board of Ophthalmology (EBO) advocate for competency‐based medical education (CBME), standardized training frameworks, and harmonized assessments across Europe. Methods: In 2023, a survey among European ophthalmologists demonstrated broad consensus on establishing unified training requirements. Subsequently, a Core Working Group developed European Training Requirements (ETRs) for ophthalmology, detailing curricula, subspecialty rotations, and Entrustable Professional Activities (EPAs) across a structured four‐year residency. Results: These ETRs, formally approved by UEMS in October 2024, incorporate simulation‐based training, workplace‐based assessments (WPBA), and innovative evaluation methods such as electronic portfolios. Certification as a European Specialist in Ophthalmology involves passing rigorous summative assessments, including the European Board of Ophthalmology Diploma (EBOD) examination. Training institutions must offer substantial clinical exposure, robust infrastructure, and comprehensive educational resources. Faculty support, continuous quality assurance, regular audits, and clinical governance frameworks are essential. Conclusion: The ETRs also highlight the importance of interprofessional collaboration and encourage subspecialty expansion in emerging areas like ophthalmic oncology and global ophthalmology. Designed as a dynamic, “living document,” the ETRs will evolve with scientific and technological advancements, supporting high‐quality ophthalmic education and practice while respecting national diversity and sovereignty.
- Open Access
- 24 November 2023
- Published by MDPI AG in Biomedicines
- Vol. 11 (12) , 3126
Differential Study of Retinal Thicknesses in the Eyes of Alzheimer’s Patients, Multiple Sclerosis Patients and Healthy Subjects
Multiple sclerosis (MS) and Alzheimer’s disease (AD) cause retinal thinning that is detectable in vivo using optical coherence tomography (OCT). To date, no papers have compared the two diseases in terms of the structural differences they produce in the retina. The purpose of this study is to analyse and compare the neuroretinal structure in MS patients, AD patients and healthy subjects using OCT. Spectral domain OCT was performed on 21 AD patients, 33 MS patients and 19 control subjects using the Posterior Pole protocol. The area under the receiver operating characteristic (AUROC) curve was used to analyse the differences between the cohorts in nine regions of the retinal nerve fibre layer (RNFL), ganglion cell layer (GCL), inner plexiform layer (IPL) and outer nuclear layer (ONL). The main differences between MS and AD are found in the ONL, in practically all the regions analysed (AUROCFOVEAL = 0.80, AUROCPARAFOVEAL = 0.85, AUROCPERIFOVEAL = 0.80, AUROC_PMB = 0.77, AUROCPARAMACULAR = 0.85, AUROCINFERO_NASAL = 0.75, AUROCINFERO_TEMPORAL = 0.83), and in the paramacular zone (AUROCPARAMACULAR = 0.75) and infero-temporal quadrant (AUROCINFERO_TEMPORAL = 0.80) of the GCL. In conclusion, our findings suggest that OCT data analysis could facilitate the differential diagnosis of MS and AD.
- 24 November 2023
- Published by MDPI AG in Biomedicines
- Vol. 11 (12) , 3126
Open AccessDifferential Study of Retinal Thicknesses in the Eyes of Alzheimer’s Patients, Multiple Sclerosis Patients and Healthy Subjects
Multiple sclerosis (MS) and Alzheimer’s disease (AD) cause retinal thinning that is detectable in vivo using optical coherence tomography (OCT). To date, no papers have compared the two diseases in terms of the structural differences they produce in the retina. The purpose of this study is to analyse and compare the neuroretinal structure in MS patients, AD patients and healthy subjects using OCT. Spectral domain OCT was performed on 21 AD patients, 33 MS patients and 19 control subjects using the Posterior Pole protocol. The area under the receiver operating characteristic (AUROC) curve was used to analyse the differences between the cohorts in nine regions of the retinal nerve fibre layer (RNFL), ganglion cell layer (GCL), inner plexiform layer (IPL) and outer nuclear layer (ONL). The main differences between MS and AD are found in the ONL, in practically all the regions analysed (AUROCFOVEAL = 0.80, AUROCPARAFOVEAL = 0.85, AUROCPERIFOVEAL = 0.80, AUROC_PMB = 0.77, AUROCPARAMACULAR = 0.85, AUROCINFERO_NASAL = 0.75, AUROCINFERO_TEMPORAL = 0.83), and in the paramacular zone (AUROCPARAMACULAR = 0.75) and infero-temporal quadrant (AUROCINFERO_TEMPORAL = 0.80) of the GCL. In conclusion, our findings suggest that OCT data analysis could facilitate the differential diagnosis of MS and AD.
- 1 June 2022
- Published by Springer Nature in Eye
- Vol. 37 (7) , 1314-1319
Ability of Swept-source OCT and OCT-angiography to detect neuroretinal and vasculature changes in patients with Parkinson disease and essential tremor
Background/Objectives To evaluate the ability of swept-source optical coherence tomography (SS-OCT) implemented with angiography analysis (SS-OCTA) to detect neuro-retinal and vasculature changes in patients with Parkinson’s disease (PD) and essential tremor (ET), and to distinguish between both pathologies. Subjects/Methods A total 42 PD and 26 ET patients and 146 controls underwent retinal evaluation using SS-OCT plus OCT-Angio™. The macular (m) and peripapillary (p) retinal nerve fiber layer (RNFL) and ganglion cell layer (GCL), and macular vasculature were assessed. A Linear discriminant function (LDF) was calculated to evaluate the diagnostic ability of SS-OCTA in both PD and ET. Results PD patients presented a reduction in mRNFL (p < 0.005), mGCL (all sectors, p < 0.05) and pRNFL (p < 0.005) vs healthy controls, and in mRNFL and pRNFL vs ET patients (p < 0.001). ET patients showed a significant reduction in mGCL vs controls (p < 0.001). No differences were observed in the macular vasculature between groups. Predictive diagnostic variables were significant only for PD and a LDF was obtained with an area under the ROC curve of 0.796. Conclusions Neuro-retinal thinning is present in both diseases, being greater in PD. While SS-OCT could be useful in diagnosing ET and PD, the diagnostic potential for SS-OCTA based on an LDF applies only to PD, not ET.
- 1 June 2022
- Published by Springer Nature in Eye
- Vol. 37 (7) , 1314-1319
Ability of Swept-source OCT and OCT-angiography to detect neuroretinal and vasculature changes in patients with Parkinson disease and essential tremor
Background/Objectives To evaluate the ability of swept-source optical coherence tomography (SS-OCT) implemented with angiography analysis (SS-OCTA) to detect neuro-retinal and vasculature changes in patients with Parkinson’s disease (PD) and essential tremor (ET), and to distinguish between both pathologies. Subjects/Methods A total 42 PD and 26 ET patients and 146 controls underwent retinal evaluation using SS-OCT plus OCT-Angio™. The macular (m) and peripapillary (p) retinal nerve fiber layer (RNFL) and ganglion cell layer (GCL), and macular vasculature were assessed. A Linear discriminant function (LDF) was calculated to evaluate the diagnostic ability of SS-OCTA in both PD and ET. Results PD patients presented a reduction in mRNFL (p < 0.005), mGCL (all sectors, p < 0.05) and pRNFL (p < 0.005) vs healthy controls, and in mRNFL and pRNFL vs ET patients (p < 0.001). ET patients showed a significant reduction in mGCL vs controls (p < 0.001). No differences were observed in the macular vasculature between groups. Predictive diagnostic variables were significant only for PD and a LDF was obtained with an area under the ROC curve of 0.796. Conclusions Neuro-retinal thinning is present in both diseases, being greater in PD. While SS-OCT could be useful in diagnosing ET and PD, the diagnostic potential for SS-OCTA based on an LDF applies only to PD, not ET.